Clinical trial
Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma
NCT00001318 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001318 |
|---|---|
| Title | Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma |
| Official title | Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy, Mycobacterium Infections, Atypical |
| Intervention type | Drug |
| Interventions | interferon gamma |
| Enrollment | 60 |
| Start date | Aug 1, 1992 |
| Completion | Nov 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: